Exelixis
The Senior Scientist, Analytical Development, Biologics CMC supports CMC analytical development for biologic therapeutics, focusing on protein characterization using high-resolution mass spectrometry and analytical assay development for antibody-drug conjugates. The role involves developing, optimizing, and transferring analytical methods to support pre-IND and clinical-stage programs while ensuring technical quality and cost-effectiveness. The incumbent works independently and collaboratively with cross-functional teams and external partners to advance biologics development.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
12% above the average for this role
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Principal Research Scientist I - Biologics Analytical R&D
AbbVie
Director or Senior Director, CMC Protein Biologics
Scripps Research
Director or Senior Director, CMC Protein Biologics
Scripps Research
SCIENTIST, ANALYTICAL DEVELOPMENT AND MASS SPECTROMETRY
Sutro Biopharma
Principal Scientist
Synolo Therapeutics
Associate Principal Scientist – Bioassay, Cell Based Sciences, AR&D
MSD